Skip Navigation


Human Molecular Genetics Advance Access originally published online on June 2, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
13/15/1587    most recent
ddh168v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Putt, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Putt, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, No. 15 1587-1597
DOI: 10.1093/hmg/ddh168
Human Molecular Genetics, Vol. 13, No. 15 © Oxford University Press 2004; all rights reserved

Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II

Wendy Putt1,{dagger}, Jutta Palmen1,{dagger}, Viviane Nicaud2,{dagger}, David-Alexandre Tregouet2, Nadia Tahri-Daizadeh2, David M. Flavell1, Steve E. Humphries1 and Philippa J. Talmud1,* on behalf of the EARSII group

1Division of Cardiovascular Genetics, Department of Medicine, Royal Free and University College Medical School, 5 University St, London WC1E 6JF, UK and 2INSERM U525, Faculté de Médecine Pitié-Salpêtrière, 91 Bd de l'Hôpital, 75013 Paris, France

Received March 24, 2004; Accepted May 21, 2004

Upstream stimulatory factor 1 (USF 1), is a transcription factor controlling expression of several genes involved in lipid and glucose homeostasis and co-localizes with familial combined hyperlipidemia (FCHL) and type 2 diabetes on chromosome 1q22–23. We sequenced USF1 in 24 UK FCHL probands, but found no rare or common cSNPs. Three common intronic single nucleotide ploymorphisms (SNP), 306A>G, 475C>T and 1748C>T, were identified and their association was examined with fasting and postprandial lipids and after an oral glucose tolerance test (OGTT) in the European Atherosclerosis Research Study II offspring study. There were no significant differences in allelic frequencies of the SNPs between cases and controls. Individually none of the SNPs showed significant associations with any parameter. In haplotype analysis, compared with other haplotypes, 475C/1748T showed significantly higher and 475T/1748T showed lower peak glucose (P=0.004 and 0.07, respectively) during the OGTT. There was significant case–control heterogeneity in the interaction of genotype with body mass index, on fasting low density lipoprotein with 306A>G and 1748C>T, and on borderline significance with fasting glucose with 475C>T (P=0.002, 0.0007 and 0.015, respectively). Furthermore, 475C>T showed interaction with both HSL–60C>G (case–control heterogeneity P=0.0002) on AUC TG and APOC3 –482C>T on plasma apoE levels (P=0.0012). Thus, in these healthy young men, variation in USF1 was the influencing feature of both glucose and lipid homeostasis showing case–control heterogeneity.

* To whom correspondence should be addressed at: Division of Cardiovascular Genetics, British Heart Foundation Laboratories, Department of Medicine, Rayne Building, Royal Free and University College Medical School, 5 University St, London WC1E 6JF, UK. Tel: +44 2076796968; Fax: +44 2076796212; Email: p.talmud{at}ucl.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
J. Naukkarinen, E. Nilsson, H. A. Koistinen, S. Soderlund, V. Lyssenko, A. Vaag, P. Poulsen, L. Groop, M.-R. Taskinen, and L. Peltonen
Functional Variant Disrupts Insulin Induction of USF1: Mechanism for USF1-Associated Dyslipidemias
Circ Cardiovasc Genet, October 1, 2009; 2(5): 522 - 529.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. J. Talmud, M. Smart, E. Presswood, J. A. Cooper, V. Nicaud, F. Drenos, J. Palmen, M. G. Marmot, S. M. Boekholdt, N. J. Wareham, et al.
ANGPTL4 E40K and T266M: Effects on Plasma Triglyceride and HDL Levels, Postprandial Responses, and CHD Risk
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2319 - 2325.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C Holzapfel, J Baumert, H Grallert, A M Muller, B Thorand, N Khuseyinova, C Herder, C Meisinger, H Hauner, H E Wichmann, et al.
Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Eur. J. Endocrinol., October 1, 2008; 159(4): 407 - 416.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kristiansson, E. Ilveskoski, T. Lehtimaki, L. Peltonen, M. Perola, and P. J. Karhunen
Association Analysis of Allelic Variants of USF1 in Coronary Atherosclerosis
Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 983 - 989.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. P. Reiner, C. S. Carlson, N. S. Jenny, J. P. Durda, D. S. Siscovick, D. A. Nickerson, and R. P. Tracy
USF1 Gene Variants, Cardiovascular Risk, and Mortality in European Americans: Analysis of Two US Cohort Studies
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2736 - 2742.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. C. Lee, D. Weissglas-Volkov, M. Kyttala, J. S. Sinsheimer, A. Jokiaho, T. W.A. de Bruin, A. J. Lusis, M.-L. Brennan, M. M.J. van Greevenbroek, C. J.H. van der Kallen, et al.
USF1 Contributes to High Serum Lipid Levels in Dutch FCHL Families and U.S. Whites With Coronary Artery Disease
Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2222 - 2227.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Nohara, M.-a. Kawashiri, T. Claudel, M. Mizuno, M. Tsuchida, M. Takata, S. Katsuda, K. Miwa, A. Inazu, F. Kuipers, et al.
High Frequency of a Retinoid X Receptor {gamma} Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 923 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. M. van der Vleuten, A. Isaacs, A. Hijmans, C. M. van Duijn, A. F. H. Stalenhoef, and J. de Graaf
The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia
J. Lipid Res., January 1, 2007; 48(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Reue and L. Vergnes
Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Approaches to lipid metabolism gene identification and characterization in the postgenomic era
J. Lipid Res., September 1, 2006; 47(9): 1891 - 1907.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Zeggini, C. M. Damcott, R. L. Hanson, M. A. Karim, N. W. Rayner, C. J. Groves, L. J. Baier, T. C. Hale, A. T. Hattersley, G. A. Hitman, et al.
Variation Within the Gene Encoding the Upstream Stimulatory Factor 1 Does Not Influence Susceptibility to Type 2 Diabetes in Samples From Populations With Replicated Evidence of Linkage to Chromosome 1q
Diabetes, September 1, 2006; 55(9): 2541 - 2548.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
N. Shibata, T. Ohnuma, S. Higashi, M. Higashi, C. Usui, T. Ohkubo, T. Watanabe, R. Kawashima, A. Kitajima, A. Ueki, et al.
Genetic Association Between USF 1 and USF 2 Gene Polymorphisms and Japanese Alzheimer's Disease.
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2006; 61(7): 660 - 662.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Peltonen, M. Perola, J. Naukkarinen, and A. Palotie
Lessons from studying monogenic disease for common disease.
Hum. Mol. Genet., April 15, 2006; 15(suppl_1): R67 - R74.
[Full Text] [PDF]


Home page
Circ. Res.Home page
E. Pearce, D.-A. Tregouet, A. Samnegard, A. R. Morgan, C. Cox, A. Hamsten, P. Eriksson, and S. Ye
Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction
Circ. Res., November 11, 2005; 97(10): 1070 - 1076.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Gibson, S. Hercberg, and P. Froguel
Common Polymorphisms in the USF1 Gene Are Not Associated With Type 2 Diabetes in French Caucasians
Diabetes, October 1, 2005; 54(10): 3040 - 3042.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Naukkarinen, M. Gentile, A. Soro-Paavonen, J. Saarela, H. A. Koistinen, P. Pajukanta, M.-R. Taskinen, and L. Peltonen
USF1 and dyslipidemias: converging evidence for a functional intronic variant
Hum. Mol. Genet., September 1, 2005; 14(17): 2595 - 2605.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Hoffstedt, M. Ryden, H. Wahrenberg, V. van Harmelen, and P. Arner
Upstream Transcription Factor-1 Gene Polymorphism Is Associated with Increased Adipocyte Lipolysis
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5356 - 5360.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Huertas-Vazquez, C. Aguilar-Salinas, A. J. Lusis, R. M. Cantor, S. Canizales-Quinteros, J. C. Lee, L. Mariana-Nunez, R.-M. L. Riba-Ramirez, A. Jokiaho, T. Tusie-Luna, et al.
Familial Combined Hyperlipidemia in Mexicans: Association With Upstream Transcription Factor 1 and Linkage on Chromosome 16q24.1
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1985 - 1991.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.